| Serial Number | 79233960 |
| Word Mark | REVLANTE |
| Filing Date | Saturday, March 24, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 10, 2020 |
| Registration Number | 6191892 |
| Registration Date | Tuesday, November 10, 2020 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 25, 2020 |
| Goods and Services | Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 12, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | NOVARTIS AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Party Name | NOVARTIS AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | CH |
| Event Date | Event Description |
| Tuesday, March 21, 2023 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, December 28, 2022 | FINAL DECISION PROCESSED AND SENT TO IB |
| Tuesday, November 10, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, August 25, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 5, 2020 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, August 5, 2020 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 5, 2020 | NOTICE OF PUBLICATION |
| Tuesday, July 21, 2020 | ELECTRONIC RECORD REVIEW COMPLETE |
| Tuesday, July 21, 2020 | ATTORNEY REVIEW COMPLETED |
| Thursday, July 16, 2020 | CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED |
| Friday, July 3, 2020 | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED |
| Wednesday, May 27, 2020 | REG. CANCELLED - RESTORED TO PENDENCY |
| Wednesday, May 27, 2020 | ASSIGNED TO PETITION STAFF |
| Tuesday, May 26, 2020 | REQUEST TO CANCEL INADVERTENTLY ISSUED REGISTRATION RECEIVED |
| Friday, March 1, 2019 | NOTIFICATION PROCESSED BY IB |
| Wednesday, January 16, 2019 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, January 16, 2019 | FINAL DISPOSITION PROCESSED |
| Thursday, January 3, 2019 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Thursday, December 20, 2018 | CORRECTION TRANSACTION RECEIVED FROM IB |
| Tuesday, December 4, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Friday, November 2, 2018 | NOTIFICATION PROCESSED BY IB |
| Tuesday, September 18, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, September 5, 2018 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Wednesday, September 5, 2018 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 29, 2018 | NOTICE OF PUBLICATION |
| Thursday, July 5, 2018 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, July 4, 2018 | NOTICE OF PUBLICATION |
| Tuesday, June 19, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, June 19, 2018 | ASSIGNED TO EXAMINER |
| Saturday, June 16, 2018 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, June 12, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, June 11, 2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, June 7, 2018 | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |